Vanda Pharmaceuticals Inc (NASDAQ: VNDA) is -7.72% lower on its value in year-to-date trading and has touched a low of $3.71 and a high of $6.75 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VNDA stock was last observed hovering at around $4.70 in the last trading session, with the day’s loss setting it -0.28%.
Currently trading at $4.42, the stock is -2.29% and -4.55% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.98 million and changing -5.96% at the moment leaves the stock -13.07% off its SMA200. VNDA registered 8.87% gain for a year compared to 6-month loss of -13.67%. The firm has a 50-day simple moving average (SMA 50) of $4.6308 and a 200-day simple moving average (SMA200) of $5.0844.
The stock witnessed a -0.67% gain in the last 1 month and extending the period to 3 months gives it a -18.15%, and is -7.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.71% over the week and 4.19% over the month.
Vanda Pharmaceuticals Inc (VNDA) has around 368 employees, a market worth around $257.73M and $198.77M in sales. Profit margin for the company is -9.51%. Distance from 52-week low is 19.14% and -34.52% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.46%).
with sales reaching $58.52M over the same period.The EPS is expected to shrink by -175.76% this year, but quarterly earnings will post 39.64% year-over-year.
Vanda Pharmaceuticals Inc (VNDA) Top Institutional Holders
202.0 institutions hold shares in Vanda Pharmaceuticals Inc (VNDA), with institutional investors hold 79.17% of the company’s shares. The shares outstanding are 58.31M, and float is at 55.20M with Short Float at 6.78%. Institutions hold 76.68% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 8.14 million shares valued at $45.98 million. The investor’s holdings represent 14.0895% of the VNDA Shares outstanding. As of 2024-06-30, the second largest holder is RENAISSANCE TECHNOLOGIES LLC with 4.11 million shares valued at $23.24 million to account for 7.1227 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 3.43 million shares representing 5.9412% and valued at over $19.39 million, while TANG CAPITAL MANAGEMENT LLC holds 3.728 of the shares totaling 2.15 million with a market value of $12.17 million.
Vanda Pharmaceuticals Inc (VNDA) Insider Activity
The most recent transaction is an insider sale by Mitchell Stephen Ray, the company’s Director. SEC filings show that Mitchell Stephen Ray sold 5,000 shares of the company’s common stock on Nov 14 ’24 at a price of $5.17 per share for a total of $25863.0. Following the sale, the insider now owns 44857.0 shares.
Still, SEC filings show that on Jul 29 ’24, Moran Kevin Patrick (SVP, CFO & Treasurer) disposed off 2,251 shares at an average price of $5.92 for $13327.0. The insider now directly holds 228,763 shares of Vanda Pharmaceuticals Inc (VNDA).
